BIOCRYST PHARMACEUTICALS, INC. Increase (Decrease) in Interest Payable, Net
BIOCRYST PHARMACEUTICALS, INC. (BCRX) reported Increase (Decrease) in Interest Payable, Net of $0 for the 12-month period ending 2023-12-31, per its 10-K filed 2024-02-27.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInInterestPayableNet · last filed 2024-02-27
- BIOCRYST PHARMACEUTICALS, INC. increase (decrease) in interest payable, net for the quarter ending 2023-12-31 was $0.00.
- BIOCRYST PHARMACEUTICALS, INC. increase (decrease) in interest payable, net for the quarter ending 2022-12-31 was -$6.34M, a 2334.15% decline year-over-year.
- BIOCRYST PHARMACEUTICALS, INC. increase (decrease) in interest payable, net for the quarter ending 2022-09-30 was $6.34M, a 1782.79% increase year-over-year.
- BIOCRYST PHARMACEUTICALS, INC. increase (decrease) in interest payable, net for the quarter ending 2022-06-30 was $0.00, a 100.00% decline year-over-year.
- BIOCRYST PHARMACEUTICALS, INC. increase (decrease) in interest payable, net for fiscal 2023 was $0.00.
- BIOCRYST PHARMACEUTICALS, INC. increase (decrease) in interest payable, net for fiscal 2022 was $0.00, a 100.00% decline from fiscal 2021.
- BIOCRYST PHARMACEUTICALS, INC. increase (decrease) in interest payable, net for fiscal 2021 was $4.17M, a 38.40% decline from fiscal 2020.
- BIOCRYST PHARMACEUTICALS, INC. increase (decrease) in interest payable, net for fiscal 2020 was $6.77M, a 121.40% increase from fiscal 2019.
| Period end | Increase (Decrease) in Interest Payable, Net 3 month | Increase (Decrease) in Interest Payable, Net 6 month | Increase (Decrease) in Interest Payable, Net 9 month | Increase (Decrease) in Interest Payable, Net 12 month |
|---|---|---|---|---|
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-27 | $0.00 10-K · filed 2024-02-27 | ||
| 2023-09-30 | $0.00 10-Q · filed 2023-11-08 | |||
| 2022-12-31 | -$6.34M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-27 | $0.00 derived: sum of 2 quarters · filed 2024-02-27 | $0.00 derived: sum of 3 quarters · filed 2024-02-27 | $0.00 10-K · filed 2024-02-27 |
| 2022-09-30 | $6.34M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-08 | $6.34M derived: sum of 2 quarters · filed 2023-11-08 | $6.34M 10-Q · filed 2023-11-08 | $6.63M derived: sum of 4 quarters · filed 2024-02-27 |
| 2022-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-05 | $0.00 10-Q · filed 2022-08-05 | $284.00K derived: sum of 3 quarters · filed 2024-02-27 | $621.00K derived: sum of 4 quarters · filed 2024-02-27 |
| 2022-03-31 | $0.00 10-Q · filed 2022-05-09 | $284.00K derived: sum of 2 quarters · filed 2024-02-27 | $621.00K derived: sum of 3 quarters · filed 2024-02-27 | $2.29M derived: sum of 4 quarters · filed 2024-02-27 |
| 2021-12-31 | $284.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-27 | $621.00K derived: sum of 2 quarters · filed 2024-02-27 | $2.29M derived: sum of 3 quarters · filed 2024-02-27 | $4.17M 10-K · filed 2024-02-27 |
| 2021-09-30 | $337.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-04 | $2.01M derived: sum of 2 quarters · filed 2022-11-04 | $3.88M 10-Q · filed 2022-11-04 | $6.25M derived: sum of 4 quarters · filed 2023-02-27 |
| 2021-06-30 | $1.67M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-05 | $3.55M 10-Q · filed 2022-08-05 | $5.91M derived: sum of 3 quarters · filed 2023-02-27 | $7.41M derived: sum of 4 quarters · filed 2023-02-27 |
| 2021-03-31 | $1.88M 10-Q · filed 2022-05-09 | $4.24M derived: sum of 2 quarters · filed 2023-02-27 | $5.74M derived: sum of 3 quarters · filed 2023-02-27 | $7.17M derived: sum of 4 quarters · filed 2023-02-27 |
| 2020-12-31 | $2.37M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-27 | $3.86M derived: sum of 2 quarters · filed 2023-02-27 | $5.29M derived: sum of 3 quarters · filed 2023-02-27 | $6.77M 10-K · filed 2023-02-27 |
| 2020-09-30 | $1.50M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04 | $2.92M derived: sum of 2 quarters · filed 2021-11-04 | $4.40M 10-Q · filed 2021-11-04 | $5.88M derived: sum of 4 quarters · filed 2022-02-28 |
| 2020-06-30 | $1.43M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-09 | $2.90M 10-Q · filed 2021-08-09 | $4.38M derived: sum of 3 quarters · filed 2022-02-28 | $3.06M derived: sum of 4 quarters · filed 2022-02-28 |
| 2020-03-31 | $1.48M 10-Q · filed 2021-05-07 | $2.96M derived: sum of 2 quarters · filed 2022-02-28 | $1.64M derived: sum of 3 quarters · filed 2022-02-28 | $2.99M derived: sum of 4 quarters · filed 2022-02-28 |
| 2019-12-31 | $1.48M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-28 | $159.00K derived: sum of 2 quarters · filed 2022-02-28 | $1.51M derived: sum of 3 quarters · filed 2022-02-28 | $3.06M 10-K · filed 2022-02-28 |
| 2019-09-30 | -$1.32M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-06 | $31.00K derived: sum of 2 quarters · filed 2020-11-06 | $1.57M 10-Q · filed 2020-11-06 | $3.00M derived: sum of 4 quarters · filed 2021-03-01 |
| 2019-06-30 | $1.35M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-07 | $2.90M 10-Q · filed 2020-08-07 | $4.32M derived: sum of 3 quarters · filed 2021-03-01 | -$87.00K derived: sum of 4 quarters · filed 2021-03-01 |
| 2019-03-31 | $1.54M 10-Q · filed 2020-05-11 | $2.96M derived: sum of 2 quarters · filed 2021-03-01 | -$1.44M derived: sum of 3 quarters · filed 2021-03-01 | -$73.00K derived: sum of 4 quarters · filed 2021-03-01 |
| 2018-12-31 | $1.42M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01 | -$2.98M derived: sum of 2 quarters · filed 2021-03-01 | -$1.62M derived: sum of 3 quarters · filed 2021-03-01 | -$247.00K 10-K · filed 2021-03-01 |
| 2018-09-30 | -$4.41M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-08 | -$3.04M derived: sum of 2 quarters · filed 2019-11-08 | -$1.67M 10-Q · filed 2019-11-08 | -$278.00K derived: sum of 4 quarters · filed 2020-03-13 |
| 2018-06-30 | $1.37M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-08 | $2.74M 10-Q · filed 2019-08-08 | $4.13M derived: sum of 3 quarters · filed 2020-03-13 | $3.25M derived: sum of 4 quarters · filed 2020-03-13 |
| 2018-03-31 | $1.37M 10-Q · filed 2019-05-09 | $2.76M derived: sum of 2 quarters · filed 2020-03-13 | $1.88M derived: sum of 3 quarters · filed 2020-03-13 | $3.17M derived: sum of 4 quarters · filed 2020-03-13 |
| 2017-12-31 | $1.39M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-13 | $508.00K derived: sum of 2 quarters · filed 2020-03-13 | $1.80M derived: sum of 3 quarters · filed 2020-03-13 | $3.10M 10-K · filed 2020-03-13 |
| 2017-09-30 | -$882.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-08 | $414.00K derived: sum of 2 quarters · filed 2018-11-08 | $1.72M 10-Q · filed 2018-11-08 | $3.14M derived: sum of 4 quarters · filed 2019-03-14 |
| 2017-06-30 | $1.30M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-09 | $2.60M 10-Q · filed 2018-08-09 | $4.02M derived: sum of 3 quarters · filed 2019-03-14 | $2.38M derived: sum of 4 quarters · filed 2019-03-14 |
| 2017-03-31 | $1.30M 10-Q · filed 2018-05-09 | $2.73M derived: sum of 2 quarters · filed 2019-03-14 | $1.09M derived: sum of 3 quarters · filed 2019-03-14 | $2.32M derived: sum of 4 quarters · filed 2019-03-14 |
| 2016-12-31 | $1.43M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-14 | -$213.00K derived: sum of 2 quarters · filed 2019-03-14 | $1.02M derived: sum of 3 quarters · filed 2019-03-14 | $2.24M 10-K · filed 2019-03-14 |
| 2016-09-30 | -$1.64M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-08 | -$411.00K derived: sum of 2 quarters · filed 2017-11-08 | $817.00K 10-Q · filed 2017-11-08 | $2.05M derived: sum of 4 quarters · filed 2018-03-12 |
| 2016-06-30 | $1.23M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-08 | $2.46M 10-Q · filed 2017-08-08 | $3.69M derived: sum of 3 quarters · filed 2018-03-12 | $4.75M derived: sum of 4 quarters · filed 2018-03-12 |
| 2016-03-31 | $1.23M 10-Q · filed 2017-05-08 | $2.46M derived: sum of 2 quarters · filed 2018-03-12 | $3.52M derived: sum of 3 quarters · filed 2018-03-12 | $733.00K derived: sum of 4 quarters · filed 2018-03-12 |
| 2015-12-31 | $1.23M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-12 | $2.30M derived: sum of 2 quarters · filed 2018-03-12 | -$495.00K derived: sum of 3 quarters · filed 2018-03-12 | $717.00K 10-K · filed 2018-03-12 |
| 2015-09-30 | $1.07M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-08 | -$1.72M derived: sum of 2 quarters · filed 2016-11-08 | -$512.00K 10-Q · filed 2016-11-08 | $693.00K derived: sum of 4 quarters · filed 2017-02-27 |
| 2015-06-30 | -$2.79M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-08 | -$1.58M 10-Q · filed 2016-08-08 | -$374.00K derived: sum of 3 quarters · filed 2017-02-27 | $664.00K derived: sum of 4 quarters · filed 2017-02-27 |
| 2015-03-31 | $1.21M 10-Q · filed 2016-05-09 | $2.42M derived: sum of 2 quarters · filed 2017-02-27 | $3.46M derived: sum of 3 quarters · filed 2017-02-27 | $2.69M derived: sum of 4 quarters · filed 2017-02-27 |
| 2014-12-31 | $1.21M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-27 | $2.24M derived: sum of 2 quarters · filed 2017-02-27 | $1.48M derived: sum of 3 quarters · filed 2017-02-27 | $2.16M 10-K · filed 2017-02-27 |
| 2014-09-30 | $1.04M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-06 | $272.00K derived: sum of 2 quarters · filed 2015-11-06 | $957.00K 10-Q · filed 2015-11-06 | |
| 2014-06-30 | -$766.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-07 | -$81.00K 10-Q · filed 2015-08-07 | ||
| 2014-03-31 | $685.00K 10-Q · filed 2015-05-08 | |||
| 2013-09-30 | -$924.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-07 | -$334.00K derived: sum of 2 quarters · filed 2014-11-07 | $736.00K 10-Q · filed 2014-11-07 | |
| 2013-06-30 | $590.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-08 | $1.66M 10-Q · filed 2014-08-08 | ||
| 2013-03-31 | $1.07M 10-Q · filed 2014-05-09 | |||
| 2012-09-30 | -$2.57M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-08 | -$1.52M derived: sum of 2 quarters · filed 2013-11-08 | -$472.00K 10-Q · filed 2013-11-08 | |
| 2012-06-30 | $1.05M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-08 | $2.10M 10-Q · filed 2013-08-08 | ||
| 2012-03-31 | $1.05M 10-Q · filed 2013-05-09 | |||
| 2011-09-30 | -$968.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-08 | $93.00K derived: sum of 2 quarters · filed 2012-11-08 | $350.00K 10-Q · filed 2012-11-08 | |
| 2011-06-30 | $1.06M derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-08 | $1.32M 10-Q · filed 2012-08-08 | ||
| 2011-03-31 | $257.00K 10-Q · filed 2012-05-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ADMA BIOLOGICS, INC. (ADMA) | United States | $2.131B | 11.16 |
| Kodiak Sciences Inc. (KOD) | United States | $2.090B | -10.12 |
| RECURSION PHARMACEUTICALS, INC. (RXRX) | United States | $2.080B | -3.78 |
| Vericel Corp (VCEL) | United States | $2.011B | 93.97 |
| Greenland Mines Ltd (GRML) | United States | $2.362B | |
| Vir Biotechnology, Inc. (VIR) | United States | $1.814B | -6.85 |
| Beam Therapeutics Inc. (BEAM) | United States | $2.549B | -41.51 |
| NOVAVAX INC (NVAX) | United States | $1.748B | -6.26 |
| Hemab Therapeutics Holdings, Inc. (COAG) | United States | $1.672B | |
| Immunocore Holdings plc (IMCR) | $1.613B | -90.43 |